1. Home
  2. Browse Decisions
  3. F.Supp.2d
  4. 260 F.Supp.2d
  5. 260 F.Supp.2d 69 (2003)
 

TORPHARM, INC. v. THOMPSON

No. CIV.A. 03-0254(ESH).

260 F.Supp.2d 69 (2003)

TORPHARM, INC., Plaintiff, v. Tommy G. THOMPSON, et al. Defendants, and Purepac Pharmaceutical Co., Intervenor-Defendant

United States District Court, District of Columbia.

April 25, 2003.

Attorney(s) appearing for the Case

Arthur Y. Tsien, Olsson, Frank and Weeda, P.C., Washington, DC, for Plaintiff.

Andrew E. Clark, U.S. Dept. of Justice, Office of Consumer Litigation, Washington, DC, Peter Blumberg, U.S. Attorney's

Office Civ. Div., Washington, DC, for Defendants.

MEMORANDUM OPINION

HUVELLE, District Judge.

This is the latest installment in the longrunning battle to determine which will be the first company permitted to market a generic version of the drug gabapentin. Competing for this privilege—and, more importantly, for the statutory right to sell the drug for 180 days free from generic competition—are plaintiff TorPharm, Inc. ("TorPharm") and intervenor-defendant Purepac Pharmaceutical Co...

NEVER MISS A DECISION. START YOUR SUBSCRIPTION.

Uncompromising quality. Enduring impact.
Your support ensures a bright future for independent legal reporting.

As you are aware we have offered this as a free subscription over the past years and we have now made it a paid service.Look forward to your continued patronage.

GET STARTED
OR

Read it with your Leagle account.
Sign in to continue


Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases